Goldman Sachs and BNY Mellon will allow institutions to access tokenized money market funds with 24/7 settlement and blockchain-based ownership tracking.
You might also be interested in reading Bio-Techne outlines 100 basis points margin expansion for FY26 following Exosome Diagnostics divestiture.